|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/475 | |
| A61K 9/127 | |||
| A61P 35/02 | |||
| A61K 9/00 | |||
| A61K 45/06 |
| (11) | Number of the document | 3324969 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16828625.0 |
| Date of filing the European patent application | 2016-07-22 | |
| (97) | Date of publication of the European application | 2018-05-30 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/043622 |
| Date | 2016-07-22 |
| (87) | Number | WO 2017/015584 |
| Date | 2017-01-26 |
| (30) | Number | Date | Country code |
| 201562195711 P | 2015-07-22 | US |
| (72) |
MONTE, William, T., US
ABRA, Robert, Malcolm, US
LUO,Bing, US
ZHANG, Yuanpeng, US
|
| (73) |
Spectrum Pharmaceuticals, Inc.,
11500 South Eastern Avenue Suite 240, Henderson, NV 89052,
US
|
| (54) | A READY-TO-USE FORMULATION FOR VINCRISTINE SULFATE LIPOSOME INJECTION |
| A READY-TO-USE FORMULATION FOR VINCRISTINE SULFATE LIPOSOME INJECTION |